ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma

Abstract Background Cholangiocarcinoma (CHOL) is the second most common primary hepatic malignant tumor, following hepatocellular carcinoma (HCC). CHOL is highly aggressive and heterogeneous resulting in poor prognosis. The diagnosis and prognosis of CHOL has not improved in the past decade. Acyl-Co...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Shuochen Liu, Shilong Fan, Yirui Wang, Ruixiang Chen, Ziyi Wang, Yaodong Zhang, Wangjie Jiang, Yananlan Chen, Xiao Xu, Yue Yu, Changxian Li, Xiangcheng Li
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2023-05-01
Edice:	BMC Cancer
Témata:	Cholangiocarcinoma ACSL4 Prognosis Immune infiltration TCGA GEO
On-line přístup:	https://doi.org/10.1186/s12885-023-10903-5
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!